<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03366857</url>
  </required_header>
  <id_info>
    <org_study_id>1744/2017</org_study_id>
    <nct_id>NCT03366857</nct_id>
  </id_info>
  <brief_title>Effect of Supplemental Oxygen on Perioperative BNP Concentration in Cardiac Risk Patients</brief_title>
  <official_title>Effect of Supplemental Oxygen on Perioperative Brain Natriuretic Peptide Concentration in Cardiac Risk Patients - A Prospective Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Vienna</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The effect of supplemental oxygen on surgical site infections was already investigated in
      several studies before. Although, oxygen is one of the most used medical therapy in
      hospitalized patients, the influence on the cardiovascular system is still unknown. Available
      data indicate beneficial effects of supplemental oxygen on cardiovascular function. Because,
      no evidence exists concerning the perioperative period, it is our objective to investigate
      supplemental oxygen in cardiac risk patients undergoing major abdominal surgery. Due to the
      significant reduction of BNP by inhibiting sympathetic nerve activity we hypothesize that
      supplemental oxygen have beneficial effects in perioperative BNP release in cardiac risk
      patients undergoing major abdominal surgery.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 1, 2017</start_date>
  <completion_date type="Anticipated">January 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>Participants don´t know the randomized oxygen concentration. The postoperative follow up will be performed by a blinded research fellow.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Change of Postoperative Brain Natriuretic Peptide (BNP) concentration compared to preoperative baseline measurement during hospitalization</measure>
    <time_frame>Preoperative, Postoperative (within 2 hours after end of surgery), Postoperative day 1 and 3 and within 72 hours before hospital discharge</time_frame>
    <description>Perioperative BNP Concentration</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Redox Status - sORP (static oxidation-reduction potential), cORP (capacity oxidation-reduction potential)</measure>
    <time_frame>Preoperative, 2 hours after induction of anesthesia, postoperative (within 2 hours after end of surgery), Postoperative day 1 and 3 and within 72 hours before hospital discharge</time_frame>
    <description>Measurement of the Redox status using the RedoxSYS(R) system</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Catecholamine</measure>
    <time_frame>Preoperative, Postoperative (within 2 hours after end of surgery), Postoperative day 3</time_frame>
    <description>Perioperative plasma catecholamine concentration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MINS (myocardial ischemia after noncardiac surgery)</measure>
    <time_frame>Preoperative, Postoperative (within 2 hours after end of surgery), Postoperative day 1 and 3</time_frame>
    <description>Troponin T (TnT) measurement</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>vWF (von Willebrand factor) Antigen</measure>
    <time_frame>Preoperative, Postoperative (within 2 hours after end of surgery), Postoperative day 1 and 3</time_frame>
    <description>Effect of supplemental oxygen on inflammatory response using von Willebrand factor antigen</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fluid measurement</measure>
    <time_frame>Intraoperative</time_frame>
    <description>Due to the peripheral vasoconstriction of hyperoxia we measure the needed fluid for hemodynamic stability</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">260</enrollment>
  <condition>Supplemental Oxygen</condition>
  <condition>Brain Natriuretic Peptide</condition>
  <condition>Cardiac Risk Patients</condition>
  <condition>Perioperative</condition>
  <arm_group>
    <arm_group_label>30%</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants allocated to these groups will receive a FiO2 of 0.3 during the operation and for two hours postoperatively.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>80%</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants allocated to these groups will receive a FiO2 of 0.8 during the operation and for two hours postoperatively.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oxygen 30 %</intervention_name>
    <description>The oxygen concentration will be set at 30%.</description>
    <arm_group_label>30%</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oxygen 80 %</intervention_name>
    <description>The oxygen concentration will be set at 80%.</description>
    <arm_group_label>80%</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patients over 45 years on age, which fulfill 1 or more of the following 4 criteria
        undergoing non-cardiac surgery:

          1. History of coronary artery disease

          2. History of peripheral arterial disease

          3. History of stroke OR

          4. Any of 3 of 7 A) Age ≥ 70 years B) Undergoing major surgery C) History of congestive
             heart failure D) History of transient ischemic attack E) Diabetes and currently taking
             an oral hypoglycemic agent or insulin F) History of Hypertension

        Further inclusion criteria are:

          1. Written informed consent

          2. Elective major abdominal open surgery or laparoscopically assisted procedures
             scheduled to take over two hours done under general anesthesia (colorectal, urology,
             gynecology, liver and pancreatic surgery)

        Exclusion Criteria:

          1. Symptoms of infection or sepsis

          2. Preoperative inotropic therapy

          3. Patients under ICU treatment

          4. Oxygen dependent patients

          5. History of severe heart failure and/or ejection fraction &lt; 30%
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christian Reiterer, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of Vienna</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Christian Reiterer, Dr. med. univ.</last_name>
    <phone>0043 40400</phone>
    <phone_ext>20760</phone_ext>
    <email>christian.reiterer@meduniwien.ac.at</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Edith Fleischmann, Prof. Dr.</last_name>
    <phone>0043 40400</phone>
    <phone_ext>41020</phone_ext>
    <email>edith.fleischmann@meduniwien.ac.at</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Medical University of Vienna</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Reiterer, Dr</last_name>
      <phone>0043 40400</phone>
      <phone_ext>20760</phone_ext>
      <email>christian.reiterer@meduniwien.ac.at</email>
    </contact>
    <contact_backup>
      <last_name>Edith Fleischmann, Prof Dr</last_name>
      <phone>0043 40400</phone>
      <phone_ext>41020</phone_ext>
      <email>edith.fleischmann@meduniwien.ac.at</email>
    </contact_backup>
    <investigator>
      <last_name>Barbara Kabon, PD Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <reference>
    <citation>Meyhoff CS, Wetterslev J, Jorgensen LN, Henneberg SW, Høgdall C, Lundvall L, Svendsen PE, Mollerup H, Lunn TH, Simonsen I, Martinsen KR, Pulawska T, Bundgaard L, Bugge L, Hansen EG, Riber C, Gocht-Jensen P, Walker LR, Bendtsen A, Johansson G, Skovgaard N, Heltø K, Poukinski A, Korshin A, Walli A, Bulut M, Carlsson PS, Rodt SA, Lundbech LB, Rask H, Buch N, Perdawid SK, Reza J, Jensen KV, Carlsen CG, Jensen FS, Rasmussen LS; PROXI Trial Group. Effect of high perioperative oxygen fraction on surgical site infection and pulmonary complications after abdominal surgery: the PROXI randomized clinical trial. JAMA. 2009 Oct 14;302(14):1543-50. doi: 10.1001/jama.2009.1452.</citation>
    <PMID>19826023</PMID>
  </reference>
  <reference>
    <citation>Greif R, Akça O, Horn EP, Kurz A, Sessler DI; Outcomes Research Group. Supplemental perioperative oxygen to reduce the incidence of surgical-wound infection. N Engl J Med. 2000 Jan 20;342(3):161-7.</citation>
    <PMID>10639541</PMID>
  </reference>
  <reference>
    <citation>Shigemitsu M, Nishio K, Kusuyama T, Itoh S, Konno N, Katagiri T. Nocturnal oxygen therapy prevents progress of congestive heart failure with central sleep apnea. Int J Cardiol. 2007 Feb 14;115(3):354-60. Epub 2006 Jun 23.</citation>
    <PMID>16806535</PMID>
  </reference>
  <reference>
    <citation>Rodseth RN, Biccard BM, Chu R, Lurati Buse GA, Thabane L, Bakhai A, Bolliger D, Cagini L, Cahill TJ, Cardinale D, Chong CP, Cnotliwy M, Di Somma S, Fahrner R, Lim WK, Mahla E, Le Manach Y, Manikandan R, Pyun WB, Rajagopalan S, Radovic M, Schutt RC, Sessler DI, Suttie S, Vanniyasingam T, Waliszek M, Devereaux PJ. Postoperative B-type natriuretic peptide for prediction of major cardiac events in patients undergoing noncardiac surgery: systematic review and individual patient meta-analysis. Anesthesiology. 2013 Aug;119(2):270-83. doi: 10.1097/ALN.0b013e31829083f1. Review.</citation>
    <PMID>23528538</PMID>
  </reference>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 2, 2017</study_first_submitted>
  <study_first_submitted_qc>December 6, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 8, 2017</study_first_posted>
  <last_update_submitted>December 6, 2017</last_update_submitted>
  <last_update_submitted_qc>December 6, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 8, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Vienna</investigator_affiliation>
    <investigator_full_name>Christian Reiterer</investigator_full_name>
    <investigator_title>Dr. med. univ.</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

